1. Al-Fiadh AH, Andrianopoulos N, Farouque O, Yan BP, Duffy SJ, Charter K, Tongyoo S, New G, Yip T, Brennan A, Proimos G, Reid CM, Ajani AE, Clark DJ; Melbourne Interventional Group. Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes. Int J Cardiol. 2011;151(2):195-9.
  2. Andrianopoulos N, Dinh D, Duffy SJ, Clark DJ, Brennan AL, Chan W, Shardey GC, Smith JA, Yap C-H, Buxton BF, Ajani AE, and Reid CM, on behalf of the Melbourne Interventional Group and Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) Investigators. Quality control activities associated with registries in interventional cardiology and surgery. Heart, Lung, Circulation. 2011;20(3):180-6.
  3. Baumert M, Lambert E, Vaddadi G, Sari CI, Esler M, Lambert G, Sanders P, Nalivaiko E. Cardiac repolarization variability in patients with postural tachycardia syndrome during graded head-up tilt. Clin Neurophysiol. 2011;122(2):405-9.
  4. Baumert M, Schlaich MP, Nalivaiko E, Lambert E, Sari CI, Kaye DM, Elser MD, Sanders P, Lambert G. Relation between QT interval variability and cardiac sympathetic activity in hypertension. Am J Physiol Heart Circ Physiol. 2011;300(4):H1412-7.
  5. Borg ML, Andrews ZB, Duh EJ, Zechner R, Meikle PJ, Watt MJ. Pigment Epithelium-Derived Factor Regulates Lipid Metabolism via Adipose Triglyceride Lipase. Diabetes 2011;60:1458-1466.
  6. Boslem E, MacIntosh G, Preston AM, Bartley C, Busch AK, Fuller M, Laybutt DR, Meikle PJ, Biden TJ. A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking. Biochem J. 2011;435:267-276.
  7. Butler MJ, Chan W, Taylor AJ, Dart AM, Duffy SJ. Management of the no-reflow phenomenon. Pharmacology & Therapeutics. 2011;132(1):72-85. Review
  8. Chan W and Dart AM. Vascular stiffness and aging in HIV. Sexual Health. 2011;8(4):474-84.
  9. Chan W, Clark DJ, Ajani AE, Yap C-H, Andrianopoulos N, Brennan AL, Dinh D, Shardey GC, Smith JA, Reid CM, and Duffy SJ, on behalf of ASCTS and MIG Investigators. Progress Towards a National Cardiac Procedure Database – Development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) Registries. Heart, Lung, Circulation. 2011;20(1):10-18.
  10. Chu PY, Zatta A, Kiriazis H, Chin-Dusting J, Du XJ, Marshall T, Kaye DM. CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess. Circ Heart Fail. 2011 Sep;4(5):651-8.
  11. Curran JE, Meikle PJ, Blangero J. New Approaches for the Discovery of Lipid-Related Genes. Clinical Lipidology. 2011;6:495-501.
  12. Dixon JB, Straznicky NE, Lambert EA, Schlaich MP, Lambert GW. Surgical approaches to the treatment of obesity. Nat Rev Gastroenterol Hepatol. 2011;8(8): 429-37. Review
  13. Drew BG, Carey AL, Natoli AK, Formosa MF, Vizi D, Reddy-Luthmoodoo M, Weir JM, Barlow CK, van Hall G, Meikle PJ, Duffy SJ, Kingwell BA. Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus. J Lipid Res. 2011;52:572-581.
  14. Du X-J, Shaun L, Gao XM, Kiriazis H, Liu Y, Lobo A, Head GA, Dart AM. Role of intramural platelet thrombus in the pathogenesis of wall rupture and intra-ventricular thrombosis following acute myocardial infarction. Thromb Haemost. 2011;105:356-364.
  15. Eikelis N, Hennebry SC, Lambert GW, Schlaich MP. Does renalase degrade catecholamines?. Kidney Int. 2011;79(12):1380. Letter.
  16. Feldman A, Voskoboinik A, Kumar S, Morton JB, Kistler PM, Sparks PB, Vohra JK, Kalman JM. Predictors of acute and long-term success of slow pathway ablation for atrioventricular nodal reentrant tachycardia: A single centre series of 1419 consecutive patients. Pacing Clin Electrophysiol 2011; 34(8):927-33.
  17. Fernando H, Dart AM, Peter KH, Shaw JA. Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy. Thromb Haemost. 2011;105:933-44. Review.
  18. Fernando H, Bassler N, Habersberger J, Sheffield LJ, Sharma R, Dart AM, Peter KH, Shaw JA. Randomised double blind placebo controlled crossover study to determine the effects of Esomeprazole on inhibition of platelet function by clopidogrel. J Thromb Haemost. 2011;9(8);1582-9.
  19. Fröjdö S, Durand C, Molin L, Carey AL, El-Osta A, Kingwell BA, Febbraio MA, Solari F, Vidal H, Pirola L. Phosphoinositide 3-Kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Molecular and Cellular Endocrinology. 2011; 335(2):166-176.
  20. Fuller M, Tucker JN, Lang DL, Dean CJ, Fietz MJ, Meikle PJ, Hopwood JJ. Screening patients referred to a metabolic clinic for lysosomal storage disorders. J Med Genet. 2011;48:422-425.
  21. Gao XM, Yang Y, White D, Su Y, Drew B, Clinton B, Kiriazis H, Xu Q, Jennings N, Bobik A, Febbraio M, Kingwell B, Dart AM, Morand E, Du X-J. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: A predominant role of anti-inflammation. J Mol Cell Card. 2011;50:991-999.
  22. Harcourt BE, Sourris KC, Coughlan MT, Walker KZ, Dougherty SL, Andirkopoulos S, Morley AL, Chand V, Penfold S, Pete J, Thomas MC, Kingwell BA, Bierhaus A, Cooper ME, De Courten B, Forbes JM. Targeting advanced glycation in obesity related renal dysfunction. Kidney International. 2011;80(2):191-199.
  23. Harriss LR, Ajani AE, Hunt D, Shaw J, Chambers B, Dewey H, Frayne J, Beauchamp A, Duvé K, Giles GG, Harrap S, Magliano DJ, Liew D, McNeil J, Peeters A, Stebbing M, Wolfe R, Tonkin A. Accuracy of national mortality codes in identifying adjudicated cardiovascular deaths. Aust N Z J Public Health. 2011;35(5):466-76.
  24. Heck P, Kistler PM The challenging face of focal atrial tachycardia in the post AF ablation era. J Cardiovasc Electrophysiol 2011 Jul;22(7):832-8 (invited review).
  25. Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DJ, Taylor AJ. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter defibrillators for primary prevention of sudden cardiac death. Journal of the American College of Cardiology 2011; 57(7):821-8.
  26. Jordan J, Schlaich M, Redon J, Narkiewicz K, Luft FC, Grassi G, Dixon J, Lambert G, Engeli S; European Society of Hypertension Working Group on Obesity; Australian and New Zealand Obesity Society. European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular outcomes.J Hypertens. 2011;29(2):189-93. Review.
  27. Khattab AA, Windecker S, Jüni P, Hildick-Smith D, Dudek D, Andersen HR, Ibrahim R, Schuler G, Walton AS, Wahl A, Mattle HP, Meier B. Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design. Trials. 2011;28:12:56.
  28. Kiriazis H, Dart AM, Du X-J. Arterial remodeling following pressure overload by aortic constriction: An overlooked and potentially fertile research area. CEPP. 2011;38:559-561. Editorial
  29. Lam YY, Hatzinikolas G, Weir JM, Janovska A, McAinch AJ, Game P, Meikle PJ, Wittert GA. Insulin-stimulated glucose uptake and pathways regulating energy metabolism in skeletal muscle cells: The effects of subcutaneous and visceral fat, and long-chain saturated, n-3 and n-6 polyunsaturated fatty acids. Biochim Biophys Acta. 2011;1811(7-8):468-75
  30. Lambert E, Lambert G, Ika-Sari C, Dawood T, Lee K, Chopra R, Straznicky N, Eikelis N, Drew S, Tilbrook A, Dixon J, Esler M, Schlaich MP. Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men. Hypertension. 2011;58(1):43-50.
  31. Lambert E, Straznicky NE, Dawood T, Ika-Sari C, Grima M, Esler MD, Schlaich MP, Lambert GW. Change in sympathetic nerve firing pattern associated with dietary weight loss in the metabolic syndrome. Front Physiol. 2011;5:52.
  32. Lambert EA, Lambert GW. Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome. Curr Hypertens Rep. 2011;13(3):244-8. Review
  33. Lambert EA, Schlaich MP, Dawood T, Sari C, Chopra R, Barton DA, Kaye DM, Elam M, Esler MD, Lambert GW. Single-unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover. J Physiol. 2011;589(Pt 10):2597-605.
  34. Lee SPS, Dart AM, Walker KZ, O'Dea K, Chin-Dusting JPF, Skilton MR. Effect of altering dietary omega-6:omega-3 polyunsaturated fatty acid ratio on cardiovascular risk measures in patients treated with statins: a pilot study. Br J Nutr. 2011;20:1-6.
  35. Lee G, Sparks PB, Morton JB, Kistler PM, Vohra JK, Medi C, Rosso R, Teh A, Halloran K, Kalman JM. Low risk of major complications associated with antral pulmonary vein isolation for atrial fibrillation. Results of 500 consecutive ablation procedures in young patients with low prevalence of structural heart disease from a single centre. Journal of cardiovascular electrophysiology 2011; 22(2) 163-8.
  36. Lee G, Wu H, Kalman JM, Esmore D, Williams T, Snell G, Kistler PM Atrial Fibrillation Following Lung Transplantation: Double but not Single Lung Transplant Prevents Long Term Paroxysmal Atrial Fibrillation European Heart Journal 2010;31(22):2774-82.
  37. Lee G, Kalman JM, Vohra JK, Teh A, Ling H, Kistler PM. Dissociated pulmonary vein potentials following antral pulmonary vein isolation for atrial fibrillation: impact on long-term outcome. Heart 2011; 97(7):579-84.
  38. Lee G; Roberts-Thomson K, Madry A, Spence S, Teh A, Heck PM, Kumar S, Kistler PM; Morton JB; Sanders P and Kalman JM The Relationship Between Complex Signals, Short Cycle Length Activity and Dominant Frequency in Persistent AF: A High-density Epicardial Mapping Study in Humans. Heart Rhythm 2011; 8 (11): 1714-9.
  39. Liu Y, Gao XM, Fang L, Jennings NL, Su YQS, Samson AL, Kiriazis H, Wang XF, Shan L, Strugeon SA, Medcalf RL, Jackson SP, Dart AM, Du X-J. Novel role of platelets in mediating inflammatory responses and ventricular rupture or remodelling following myocardial infarction. Arterioscler Thromb Vasc Biol. 2011;31:834-841.
  40. Masuo K, Lambert GW. Relationships of adrenoceptor polymorphisms with obesity. J Obes. 2011;2011:609485. Review
  41. Masuo K, Lambert GW. Epinephrine and its role in the development of obesity and hypertension. Curr Hypertens Rev. 2011;7(3):144-52. Review.
  42. Masuo K, Rakugi H, Ogihara T, Esler MD, Lambert GW. Effects of weight loss on renal function in overweight Japanese men. Hypertens Res. 2011;34(8):915-21.
  43. Masuo K, Tuck ML, Lambert GW. Hypertension and diabetes in obesity. Int J Hypertens. 2011;2011:695869. Editorial.
  44. Medi C, Sparks PB, Morton JB, Kistler PM, Halloran K, Rosso R, Vohra JK, Kumar S, Kalman JM. Pulmonary Vein Antral Isolation for Paroxysmal Atrial Fibrillation: Results from Long-Term Follow-Up. J Cardiovasc Electrophysiol 2011; 22 (2): 137-41.
  45. Medi C, Kalman JM, Spence SJ, Teh AW, Lee G, Bader I, Kaye DM, Kistler PM. Atrial electrical and structural changes associated with long standing hypertension in humans: implications for the substrate for atrial fibrillation. J Cardiovasc Electrophysiol 2011 22(12): 1317-24.
  46. Meikle PJ, Wong G, Tsorotes D, Barlow CK, Weir JM, Christopher MJ, MacIntosh GL, Goudey B, Stern L, Kowalczyk A, Haviv I, White AJ, Dart AM, Duffy SJ, Jennings GL, Kingwell BA. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol. 2011;31:2723-2732.
  47. Meikle PJ, Christopher MJ. Lipidomics is providing new insight into the metabolic syndrome and its sequelae. Curr Opin Lipidol. 2011;22:210-215.
  48. Michell DL, Andrews KL, Chin-Dusting J. Review: Endothelial dysfunction in hypertension: The role of arginase. Front Biosci (Schol Ed). 2011;3:946-60.
  49. Michell DL, Andrews KL, Woollard KJ, Chin-Dusting JP. Imaging Leukocyte Adhesion to the Endothelium at High Intraluminal Pressure. Journal of Visual Experimentation. 2011;Aug 23:(54).
  50. Murphy A, Woollard K, Suhartoyo, Stirzaker, Shaw J, Sviridov D, Chin-Dusting J. Neutrophil activation is attenuated by high density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arteriosclerosis, Thrombosis, Vascular Biology. 2011;31(6):1333-41.
  51. Rossi P, Frances Y, Kingwell BA, Ahimastos AA. Gender differences in artery wall biomechanical properties throughout life. J Hypertension. 2011;29(6):1023-1033.
  52. Schlaich MP, Straznicky N, Grima M, Ika-Sari C, Dawood T, Mahfoud F, Lambert E, Chopra R, Socratous F, Hennebry S, Eikelis N, Böhm M, Krum H, Lambert G, Esler MD, Sobotka PA. Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens. 2011;29(5):991-6.
  53. Skilton MR, Chin-Dusting JP, Dart AM, Brazionis L, Lantieri O, O'Dea K, Balkau B. Metabolic health, obesity and 9-year incidence of peripheral arterial disease: The D.E.S.I.R. study. Atherosclerosis. 2011;216:471-6.
  54. Soldatos G, Jandeleit-Dahm K, Thomson H, Ahimastos A, Formosa M, D'Orsa K, Calkin A, Cooper ME, Kingwell BA. Large artery biomechanics and diastolic dysfunction in patients with type 2 diabetes. Diabetic Medicine. 2011;28(1):54-60.
  55. Sozo F, Vela M, Stokes V, Kenna K, Meikle PJ, De Matteo R, Walker D, Brien J, Bocking A, Harding R. Effects of prenatal ethanol exposure on the lungs of postnatal lambs. Am J Physiol Lung Cell Mol Physiol. 2011;300:L139-147.
  56. Straznicky NE, Grima MT, Eikelis N, Nestel PJ, Dawood T, Schlaich MP, Chopra R, Masuo K, Esler MD, Sari CI, Lambert GW, Lambert EA. The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components. J Clin Endocrinol Metab. 2011;96(3):E503-8
  57. Straznicky NE, Grima MT, Lambert EA, Eikelis N, Dawood T, Lambert GW, Nestel PJ, Masuo K, Sari CI, Chopra R, Mariani JA, Schlaich MP. Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals. J Hypertens. 2011;29(3):553-64.
  58. Stub D, Hengel C, Chan W, Jackson D, Sanders K, Dart AM, Hilton A, Pellegrino V, Shaw JA, Duffy SJ, Bernard S, Kaye DM. Usefulness of cooling and coronary catheterization to improve survival in out-of-hospital cardiac arrest. Am J Cardiol. 2011;107(4):522-7.
  59. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57(5):911-7.
  60. Teh AW, Medi C, Lee G, Rosso R, Sparks PB, Morton JB, Kistler PM, Halloran K, Vohra JK, Kalman JM Long-term Outcome Following Ablation of Atrial Flutter Occurring Late after Atrial Septal Defect Repair. Pacing Clin Electrophysiol. 2011; 34(4):431-5
  61. Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence SJ, Sparks PB, Morton JB, Kalman JM. Electroanatomic Remodeling of the Left Atrium in Paroxysmal and Persistent Atrial Fibrillation Patients Without Structural Heart Disease. J Cardiovasc Electrophysiol. 2011 Sep 22 (10):1083-91.
  62. Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence SJ, Sparks PB, Morton JB, Sanders P, Kalman JM. The relationship between complex fractionated electrograms and atrial low-voltage zones during atrial fibrillation and paced rhythm. Europace 2011 Dec;13(12):1709-16.
  63. Vaddadi G, Guo L, Esler M, Socratous F, Schlaich M, Chopra R, Eikelis N, Lambert G, Trauer T, Lambert E. Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes. Circ Arrhythmia Electrophysiol. 2011;4(5):711-8.
  64. Xu Q, Dalic A, Fang L, Kiriazis H, Ritchie R, Sim K, Gao XM, Drummond G, Sarwar M, Zhang YY, Dart AM, Du X-J. Myocardial oxidative stress contributes to transgenic β(2)-adrenoceptor activation-induced cardiomyopathy and heart failure. Br J Pharmacol. 2011;162:1012-1028.
  65. Yan BP, Ajani AE, Clark DJ, Duffy SJ, Andrianopoulos N, Brennan AL, Loane P and Reid CM. Recent trends in Australian percutaneous coronary intervention practice: insights from the Melbourne Interventional Group registry. MJA. 2011;195:3-1.
  66. Zentner D, Hunt D, Chan W, Barzi F, Grigg L, Perkovic V. Prospective evaluation of aortic stenosis in end stage kidney disease: a more fulminant process? Nephrology Dialysis Transplantation. 2011;26(5):1651-5.

Book Chapters

  1. Eikelis N, Lambert G. The brain and leptin resistance and implications for food-related disorders. In: Preedy V, Watson RR, Martin CR (eds), Handbook of Behavior, Food and Nutrition, Springer NY. 2011;1301-15. Book chapter.
  2. Esler M, Alvarenga M, Kaye D, Lambert G, Thompson J, Hastings J, Schwarz R, Morris M, Richards J. Panic Disorder In: Robertson D, Biaggioni I, Burnstock G, Low P, Paton J (eds), Primer on the Autonomic Nervous System, 3rd edition, Academic Press Inc, USA. 2011;Chapter 126:605-8. Book chapter
  3. Masuo K, Lambert GW. Treatments for hypertension in Type 2 diabetes-non-pharmacological and pharmacological measurements. In: Zimgering M (ed), Recent Advances in the Pathogenesis, Prevention and Management of Type 2 Diabetes and its Complications, InTech, Croatia. 2011; Chapter 13:233-62. Book chapter.
  4. Masuo K, Lambert GW. Treatments for hypertension in Type 2 diabetes-non-pharmacological and pharmacological measurements. In: Zimering M (ed), Recent Advances in the Pathogenesis, Prevention and Management of Type 2 Diabetes and its Complications, InTech USA. 2011;Chapter 13:233-62. Book chapter
  5. Masuo K, Lambert GW, Esler MD. Epinephrine and its role in the development of obesity, hypertension and obesity-related hypertension. In: Berhardt L (ed), Advances in Medicine and Biology, Volume 17, Nova Publishers Inc., New York, USA. 2011;61-77. Book chapter
  6. McDonald D, McDonald K, Lambert G. DEXA-Dan: Embedding the corporeal body. In: Fischer G, Vassen F (eds), Collective creativity : collaborative work in the sciences, literature and the arts, Rodopi, Amsterdam. 2011;143-57. Book chapter.



Consultation in the Heart Centre is only by referral from a Medical Practitioner.



Please follow the link to find further information



‘This just doesn’t happen to people like me.’  aged 50...

Support US


Donate or Volunteer for research study. See how you can help.

Copyright © Alferd Health Victoria 2013 | Login